Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies
about
Impaired antibody response causes persistence of prototypic T cell-contained virusRapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis CAutoreactivity and Exceptional CDR Plasticity (but Not Unusual Polyspecificity) Hinder Elicitation of the Anti-HIV Antibody 4E10Immune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected miceType I interferon suppresses virus-specific B cell responses by modulating CD8(+) T cell differentiationInflammatory monocytes hinder antiviral B cell responses.Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection.Neutralizing antibodies in hepatitis C virus infection.Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.Elimination of chronic viral infection by blocking CD27 signaling.Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus.Antiviral antibody responses: the two extremes of a wide spectrum.Low-affinity B cells transport viral particles from the lung to the spleen to initiate antibody responsesMapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.Interferon-driven deletion of antiviral B cells at the onset of chronic infection.Kinetics of protective antibodies are determined by the viral surface antigen.Immunological memory ≠ protective immunity.Pathogen-specific B-cell receptors drive chronic lymphocytic leukemia by light-chain-dependent cross-reaction with autoantigens.The VP6 protein of rotavirus interacts with a large fraction of human naive B cells via surface immunoglobulins.Bisphosphonates target B cells to enhance humoral immune responses.Deliberate removal of T cell help improves virus-neutralizing antibody production.
P2860
Q27331309-E779AB4D-E787-43D0-BDA0-328CE540CD95Q27478257-18995F43-485A-4DAF-A35D-BBFA4641A0E9Q27680125-ACA18634-A3F7-4A34-AF80-2B122FA5E13CQ28748570-D4A00C97-1CCD-42F4-8A3D-752B639A30B5Q30827049-D1293EA0-22EE-4FF4-992A-6C761C2C83E7Q30828890-7E3C8D59-44FE-492A-90DC-E409F8B74728Q33665625-7101C292-41AF-4F13-9D91-E672113B12F3Q36179699-95584069-5B9B-491D-A1BA-C6333DB37B5CQ36228781-92AE1874-A044-4246-A0C8-0FD3072A3E55Q36228882-DCDE02DE-96D4-4965-8A47-DA05100E2797Q36314976-6CBFB5BF-4FF9-49C3-B688-EEFE996DDE07Q36405084-E862D2DE-1243-4D90-BA3B-9851AECD7C3FQ36483586-167E9295-29F9-41C3-A0B6-6B6C617A3E0BQ36780133-84E2AE14-BC6E-487A-A0B7-D7452D75D397Q37423183-C1C30E0B-F2F5-479D-8A3F-4167A82A1FF2Q37532751-12E2E099-35EB-4289-AE70-1DEFA6E9EA4DQ38000488-8FC80FF5-0E43-4EDB-BADE-0E99E1540433Q40044803-AB1E46AD-6AB9-4FDA-8F57-D14A96E1BA8EQ40276522-C17C7D82-555B-4E16-B83E-5D0953DFFA52Q42043218-85461DCA-D817-4039-A981-EA406E18DD76Q45603036-99E08DF7-323C-4028-A6B7-CB1F8365BBC8
P2860
Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Antiviral immune responses in ...... virus-neutralizing antibodies
@ast
Antiviral immune responses in ...... virus-neutralizing antibodies
@en
type
label
Antiviral immune responses in ...... virus-neutralizing antibodies
@ast
Antiviral immune responses in ...... virus-neutralizing antibodies
@en
prefLabel
Antiviral immune responses in ...... virus-neutralizing antibodies
@ast
Antiviral immune responses in ...... virus-neutralizing antibodies
@en
P2093
P2860
P356
P1476
Antiviral immune responses in ...... virus-neutralizing antibodies
@en
P2093
Beatrice M Senn
Bernhard Odermatt
Birgit Ledermann
Etienne Bucher
Hans Hengartner
Katja Fink
Kurt Bürki
Lars Hangartner
Peter Seiler
Rolf M Zinkernagel
P2860
P304
12883-12888
P356
10.1073/PNAS.2135542100
P407
P577
2003-10-20T00:00:00Z